Dexamethasone implant in diabetic macular edema – (Eye 30, 1650 (December 2016))
Dexamethasone implant in diabetic macular edema Eye 30, 1650 (December 2016). doi:10.1038/eye.2016.192 Author: J Chhablani
Annual acknowledgement of manuscript reviewers – (Eye 30, 1527 (December 2016))
Annual acknowledgement of manuscript reviewers Eye 30, 1527 (December 2016). doi:10.1038/eye.2016.262
Aflibercept in diabetic macular edema: evaluating efficacy as a primary and secondary therapeutic option – (Eye 30, 1531 (December 2016))
Aflibercept in diabetic macular edema: evaluating efficacy as a primary and secondary therapeutic option Eye 30, 1531 (December 2016). doi:10.1038/eye.2016.174 Authors: M Ashraf, A Souka, R Adelman & S H Forster
A challenge to the striking genotypic heterogeneity of retinitis pigmentosa: a better understanding of the pathophysiology using the newest genetic strategies – (Eye 30, 1542 (December 2016))
A challenge to the striking genotypic heterogeneity of retinitis pigmentosa: a better understanding of the pathophysiology using the newest genetic strategies Eye 30, 1542 (December 2016). doi:10.1038/eye.2016.197 Authors: F S Sorrentino, C E Gallenga, C Bonifazzi & P Perri
Intravitreal dexamethasone implant for recurrent cystoid macular edema due to Irvine–Gass syndrome: a prospective case series – (Eye 30, 1549 (December 2016))
Intravitreal dexamethasone implant for recurrent cystoid macular edema due to Irvine–Gass syndrome: a prospective case series Eye 30, 1549 (December 2016). doi:10.1038/eye.2016.205 Authors: A Sudhalkar, J Chhablani, A Vasavada, D Bhojwani, V Vasavada & S Vasavada